Gatifloxacin versus ceftriaxone for uncomplicated enteric fever in Nepal: an open-label, two-centre, randomised controlled trial

BACKGROUND: Because treatment with third-generation cephalosporins is associated with slow clinical improvement and high relapse burden for enteric fever, whereas the fluoroquinolone gatifloxacin is associated with rapid fever clearance and low relapse burden, we postulated that gatifloxacin would b...

全面介紹

Na minha lista:
書目詳細資料
發表在:Lancet Infect Dis
Main Authors: Arjyal, Amit, Basnyat, Buddha, Nhan, Ho Thi, Koirala, Samir, Giri, Abhishek, Joshi, Niva, Shakya, Mila, Pathak, Kamal Raj, Mahat, Saruna Pathak, Prajapati, Shanti Pradhan, Adhikari, Nabin, Thapa, Rajkumar, Merson, Laura, Gajurel, Damodar, Lamsal, Kamal, Lamsal, Dinesh, Yadav, Bharat Kumar, Shah, Ganesh, Shrestha, Poojan, Dongol, Sabina, Karkey, Abhilasha, Thompson, Corinne N, Thieu, Nga Tran Vu, Thanh, Duy Pham, Baker, Stephen, Thwaites, Guy E, Wolbers, Marcel, Dolecek, Christiane
格式: Artigo
語言:Inglês
出版: Elsevier Science ;, The Lancet Pub. Group 2016
主題:
Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4835582/
https://ncbi.nlm.nih.gov/pubmed/26809813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(15)00530-7
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍